| Aliskiren monotherapy does not cause paradoxical blood pressure rises: meta-analysis of data from 8 clinical trials. | |
| | |
MedLine Citation:
|
PMID: 19917876 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Angiotensin receptor blockers, angiotensin-converting enzyme inhibitors, and diuretics all cause reactive rises in plasma renin concentration, but particularly high levels have been reported with aliskiren. This prompted speculation that blockade of plasma renin activity with aliskiren could be overwhelmed, leading to paradoxical increases in blood pressure. This meta-analysis of data from 4877 patients from 8 randomized, double-blind, placebo- and/or active-controlled trials examined this hypothesis. The analysis focused on the incidence of paradoxical blood pressure increases above predefined thresholds, after > or =4 weeks of treatment with 300 mg of aliskiren, angiotensin receptor blockers (300 mg of irbesartan, 100 mg of losartan, or 320 mg of valsartan), 10 mg of ramipril, 25 mg of hydrochlorothiazide, or placebo. There were no significant differences in the frequency of increases in systolic (>10 mm Hg; P=0.30) or diastolic (>5 mm Hg; P=0.65) pressure among those treated with aliskiren (3.9% and 3.1%, respectively), angiotensin receptor blockers (4.0% and 3.7%), ramipril (5.7% and 2.6%), or hydrochlorothiazide (4.4% and 2.7%). Increases in blood pressure were considerably more frequent in the placebo group (12.6% and 11.4%; P<0.001). None of the 536 patients with plasma renin activity data who received 300 mg of aliskiren exhibited an increase in systolic pressure >10 mm Hg that was associated with an increase in plasma renin activity >0.1 ng/mL per hour. In conclusion, the incidence of blood pressure increases with aliskiren was similar to that during treatment with other antihypertensive drugs. Blood pressure rises on aliskiren treatment were not associated with increases in plasma renin activity. This meta-analysis found no evidence that aliskiren uniquely causes paradoxical rises in blood pressure. |
| | |
Authors:
|
Alice V Stanton; Alan H Gradman; Roland E Schmieder; Juerg Nussberger; Ramesh Sarangapani; Margaret F Prescott |
Related Documents
:
|
7113766 - A bartter-like syndrome after jejunoileal bypass for obesity. 11967726 - Angiotensin ii as a cardiovascular risk factor. 1725196 - Angiotensin-converting enzyme inhibition and vascular structure in hypertension. 2225556 - Disappearance of renin-induced proteinuria by an ace-inhibitor: a case report. 17474556 - Association between biomarkers of inflammation and left ventricular hypertrophy in mode... 10505426 - Uncoupling between left ventricular contractility and relaxation after direct-current c... |
Publication Detail:
|
Type: Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't Date: 2009-11-16 |
Journal Detail:
|
Title: Hypertension Volume: 55 ISSN: 1524-4563 ISO Abbreviation: Hypertension Publication Date: 2010 Jan |
Date Detail:
|
Created Date: 2009-12-18 Completed Date: 2010-01-21 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 7906255 Medline TA: Hypertension Country: United States |
Other Details:
|
Languages: eng Pagination: 54-60 Citation Subset: IM |
Affiliation:
|
Molecular and Cellular Therapeutics, Royal College of Surgeons in Ireland, St. Stephen's Green, Dublin 2, Ireland. astanton@rcsi.ie |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Aged Amides / adverse effects, therapeutic use* Antihypertensive Agents / adverse effects, therapeutic use Blood Pressure / drug effects* Fumarates / adverse effects, therapeutic use* Humans Hypertension / blood, drug therapy*, physiopathology Middle Aged Randomized Controlled Trials as Topic Renin / antagonists & inhibitors, blood Treatment Outcome |
| Chemical | |
Reg. No./Substance:
|
0/Amides; 0/Antihypertensive Agents; 0/Fumarates; 0/aliskiren; EC 3.4.23.15/Renin |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Sex Differences in Pulse Pressure Trends With Age Are Cross-Cultural.
Next Document: Lack of glutathione peroxidase 1 accelerates cardiac-specific hypertrophy and dysfunction in angiote...